International Flavors and Fragrances Inc (IFF) Actualités

IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility

At our new, state-of-the-art facility, IFF will produce high-quality fruit-based ingredients for snack manufacturers, aiming to provide a...

Form 8-K - Current report

IFF Announces Executive Leadership Team Aligned With New Operating Model

IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure. After 21 years of...

Form 8-K - Current report

IFF Reports Fourth Quarter and Full Year 2024 Results

International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

IFF Announces Launch of New IFF.com

IFF Announces Launch of New IFF.com PR Newswire NEW YORK, Feb. 13, 2025 NEW YORK, Feb. 13, 2025 /PRNewswire/...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

IFF Adds Real-Time Consumer Feedback into Fragrance Creation with Introduction of AI-Powered ScentChat™ App

IFF Adds Real-Time Consumer Feedback into Fragrance Creation with Introduction of AI-Powered ScentChat™ App PR Newswire PARIS, Feb. 4, 2025...

IFF to Release Fourth Quarter & Full Year 2024 Results on Feb. 18, 2025; IFF to Present at 2025 CAGNY Conference on Feb. 20, 2025

IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday...

Form 4 - Statement of changes in beneficial ownership of securities

IFF Launches Enviva® DUO to Boost Poultry Welfare

IFF Launches Enviva® DUO to Boost Poultry Welfare PR Newswire NEW YORK, Jan. 15, 2025 Formulated for waterline...

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award PR Newswire NEW YORK, Jan. 14, 2025...